Literature DB >> 27270720

Perspectives on Dual Targeting Delivery Systems for Brain Tumors.

Huile Gao1.   

Abstract

Brain tumor remains one of the most serious threats to human beings. Different from peripheral tumors, drug delivery to brain tumor is largely restricted by the blood brain barrier (BBB). To fully conquer this barrier and specifically deliver drugs to brain tumor, dual targeting delivery systems were explored, which are functionalized with two active targeting ligands: one to the BBB and the other to the brain tumor. The development of dual targeting delivery system is still in its early stage, and attentions need to be paid to issues and concerns that remain unresolved in future studies.

Entities:  

Keywords:  Blood brain barrier; Brain tumor; Drug delivery systems; Dual targeting

Mesh:

Substances:

Year:  2016        PMID: 27270720     DOI: 10.1007/s11481-016-9687-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  91 in total

1.  Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.

Authors:  A M Butt; H C Jones; N J Abbott
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

Review 2.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

3.  Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.

Authors:  Y Joy Yu; Yin Zhang; Margaret Kenrick; Kwame Hoyte; Wilman Luk; Yanmei Lu; Jasvinder Atwal; J Michael Elliott; Saileta Prabhu; Ryan J Watts; Mark S Dennis
Journal:  Sci Transl Med       Date:  2011-05-25       Impact factor: 17.956

4.  Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.

Authors:  Jianwei Guo; Xiaoling Gao; Lina Su; Huimin Xia; Guangzhi Gu; Zhiqing Pang; Xinguo Jiang; Lei Yao; Jun Chen; Hongzhuan Chen
Journal:  Biomaterials       Date:  2011-07-23       Impact factor: 12.479

5.  Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.

Authors:  Shaobo Ruan; Xi Cao; Xingli Cun; Guanlian Hu; Yi Zhou; Yijia Zhang; Libao Lu; Qin He; Huile Gao
Journal:  Biomaterials       Date:  2015-05-15       Impact factor: 12.479

6.  Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.

Authors:  Suraj Dixit; Kayla Miller; Yun Zhu; Emilie McKinnon; Thomas Novak; Malcolm E Kenney; Ann-Marie Broome
Journal:  Mol Pharm       Date:  2015-08-24       Impact factor: 4.939

7.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

8.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

Review 9.  Nanopharmaceuticals (part 1): products on the market.

Authors:  Volkmar Weissig; Tracy K Pettinger; Nicole Murdock
Journal:  Int J Nanomedicine       Date:  2014-09-15

10.  Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Alioscka A Sousa; Colin M Wilson; Maria A Aronova; Gary L Griffiths; Richard D Leapman; Howard Q Vo
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

View more
  29 in total

1.  Nanomedicines for the Treatment of CNS Diseases.

Authors:  Jessica L Reynolds; Ram I Mahato
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-01       Impact factor: 4.147

2.  Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection.

Authors:  Xueqin He; Xiaorong Wang; Lianyi Yang; Zhihang Yang; Wenqi Yu; Yazhen Wang; Rui Liu; Meiwan Chen; Huile Gao
Journal:  Acta Pharm Sin B       Date:  2022-02-10       Impact factor: 14.903

3.  A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.

Authors:  Imran Shair Mohammad; Wei He; Lifang Yin
Journal:  Pharm Res       Date:  2018-02-27       Impact factor: 4.200

4.  Dual Antibody-Conjugated Amyloid Nanorods to Promote Selective Cell-Cell Interactions.

Authors:  Weiqiang Wang; Marcos Gil-Garcia; Salvador Ventura
Journal:  ACS Appl Mater Interfaces       Date:  2021-03-24       Impact factor: 10.383

5.  Application of dual targeting drug delivery system for the improvement of anti-glioma efficacy of doxorubicin.

Authors:  Zhenliang Sun; Xuebing Yan; YiBo Liu; Linsheng Huang; Cheng Kong; Xiao Qu; Man Wang; Renyuan Gao; Huanlong Qin
Journal:  Oncotarget       Date:  2017-07-13

6.  Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment.

Authors:  Naveed Ullah Khan; Jiang Ni; Xiufeng Ju; Tongtong Miao; Haiyan Chen; Liang Han
Journal:  Acta Pharm Sin B       Date:  2020-10-21       Impact factor: 11.413

7.  From blood to brain: blood cell-based biomimetic drug delivery systems.

Authors:  Yong-Jiang Li; Jun-Yong Wu; Jihua Liu; Xiaohan Qiu; Wenjie Xu; Tiantian Tang; Da-Xiong Xiang
Journal:  Drug Deliv       Date:  2021-06-18       Impact factor: 6.819

8.  Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment.

Authors:  Zakia Belhadj; Changyou Zhan; Man Ying; Xiaoli Wei; Cao Xie; Zhiqiang Yan; Weiyue Lu
Journal:  Oncotarget       Date:  2017-05-18

Review 9.  Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.

Authors:  L Nam; C Coll; L C S Erthal; C de la Torre; D Serrano; R Martínez-Máñez; M J Santos-Martínez; E Ruiz-Hernández
Journal:  Materials (Basel)       Date:  2018-05-11       Impact factor: 3.623

10.  BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation.

Authors:  Weimin Yin; Yuge Zhao; Xuejia Kang; Pengfei Zhao; Xuhong Fu; Xiaopeng Mo; Yakun Wang; Yongzhuo Huang
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.